June 2007- Volume 3, Issue 6

June 2007

In this Issue

Genomics & Proteomics

BioServe buys Genomics Collaborative

BioServe buys Genomics Collaborative

BioServe has acquired Genomics Collaborative from SeraCare Life Sciences and its comprehensive library of 600,000 human DNA, tissue and serum samples linked to detailed clinical and demographic data from 140,000 consenting and anonymous patients.

GenomeQuest, Servier collaborate

GenomeQuest, Servier collaborate

Work leads to creation of new GQ Gene Viewer product

An acceptable third party

An acceptable third party

GeneGo looks outside for the first time, licenses GVK Bio’s medicinal chemistry database

Research & Development

Building for the future

Building for the future

AstraZeneca begins construction of $100M R&D facility in Greater Boston area

Au natural for Metabolic Research

Au natural for Metabolic Research

Company gets license for natural product technology and installs creators as chief officers

New Products

Highly Multiplexed, PCR-Based Assays

Highly Multiplexed, PCR-Based Assays

Qiagen, a provider of sample and assay technologies for research in life sciences, applied testing, and molecular diagnostics, announced the launch of the first assays based on its breakthrough QIAplex PCR multiplex technology.

Global News

Enzo Biochem to acquire Axxora Life Sciences for $16.3 million

Enzo Biochem to acquire Axxora Life Sciences for $16.3 million

Enzo Biochem Inc. announced late last month that its wholly owned subsidiary, Enzo Life Sciences Inc., signed a definitive agreement to acquire Axxora Life Sciences Inc., a privately owned global manufacturer and marketer of life sciences research products, for approximately $16.3 million in cash

BMS, Pfizer Inc. ink $1 billion blood-clot deal

BMS, Pfizer Inc. ink $1 billion blood-clot deal

Bristol-Myers Squibb Co. and Pfizer Inc. recently announced a worldwide collaboration to develop and commercialize apixaban, an anticoagulant discovered by Bristol-Myers Squibb being studied for the prevention and treatment of a broad range of venous and arterial thrombotic conditions.

Micromet, Nycomed collaborate on anti-GM-CSF antibodies

Micromet, Nycomed collaborate on anti-GM-CSF antibodies

Micromet Inc. and Nycomed have announced an agreement under which the two companies will collaborate on the development of anti-GM-CSF antibodies that may be useful for the treatment of inflammatory and autoimmune diseases.

Avexa wins $4.3 million AUD grant for anti-HIV drug discovery program

Avexa wins $4.3 million AUD grant for anti-HIV drug discovery program

Avexa announced in May that it was awarded an Australian Government Commercial Ready Grant worth $4.3 million AUD to develop a new generation of HIV antiviral drugs using fragment-based drug design, a non-traditional research methodology.

Ranbaxy Labs expands U.S. dermatology market presence

Ranbaxy Labs expands U.S. dermatology market presence

Ranbaxy Laboratories Inc., a wholly owned subsidiary of Ranbaxy Laboratories Limited, recently announced that it acquired from Bristol-Myers Squibb Co. the U.S. rights to a group of 13 dermatology products.

Automation & Instrumentation

Impressive array of partners

Impressive array of partners

Looking to promote the nascent market for high-throughput genotyping and gene expression in a clinical laboratory setting, Affymetrix Clinical Services Laboratory (ACSL), Agencourt Biosciences, Beckman Coulter Inc. and NuGEN Technologies announced a successful collaboration between the companies to bring forward an automated, reproducible service offering for DNA purification and genetic analysis.

Reaching the “flash point” -- PerkinElmer’s photonics license deal with Axxam is focused on drug discovery

Reaching the “flash point” -- PerkinElmer’s photonics license deal with Axxam is focused on drug discovery

PerkinElmer Inc., which already considers itself a global technology leader in health sciences and photonics, recently bolstered both areas by signing a worldwide licensing agreement with Axxam SpA, a Milan, Italy-based company focused on early-stage discovery research and services for the life science industry.

Peteros and BI ink protein analysis agreement

Peteros and BI ink protein analysis agreement

Proteros Biostructures GmbH recently entered into a research collaboration with Ridgefield, Conn.-based Boehringer Ingelheim Pharmaceuticals in the field of protein crystallography, in an 18-month agreement under which Proteros will receive research funding fees and milestone payments for the generation and analyses of protein-ligand-structures of hits and evolved chemical entities from in-house Boehringer Ingelheim programs.

Aspectrics teams with Thermo for EP-NIR technology

Aspectrics teams with Thermo for EP-NIR technology

Aspectrics Inc., which produces encoded photometric infrared (EP-IR) technology, has entered into an exclusive agreement with Thermo Fisher Scientific to integrate Thermo Scientific GRAMS spectroscopy software with Aspectrics’ Encoded Photometric Near Infrared EP-NIR process analyzers.

Informatics

CATCHING THE BUG

CATCHING THE BUG

Antiviral InteliStrat Inc. announced in mid-May the launch of a “unique database that has no equivalent worldwide”—a Web-based product that is said to be the most complete and detailed database ever on drugs and vaccines for viral infections in humans.

Strange bedfellows -- VelQuest, Symyx merging R&D and GMP in one ELN

Strange bedfellows -- VelQuest, Symyx merging R&D and GMP in one ELN

A joint development project between VelQuest Corp. and Symyx Technologies Inc., is creating a new pharmaceutical industry alphabet soup by joining R&D and GMP in a comprehensive ELN (electronic lab notebook) software platform.

The new economics of discovery -- Entelos in silico + Jubilant BioSys outsourcing = cost reductions

The new economics of discovery -- Entelos in silico + Jubilant BioSys outsourcing = cost reductions

A new collaboration aimed at reducing risks and costs of drug discovery and development combines in silico disease models from Entelos Inc., with the India-based labs of Jubilant Biosys Ltd.

Deal bundles genetic analysis app and validation services

Deal bundles genetic analysis app and validation services

Geospiza and Pharmaceutical Services Corp. (PSC) announced in late April a collaboration joining Geospiza’s genetic analysis software with PSC’s services for validating the software for use in commercial manufacturing of gene-based diagnostics and therapies.
Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

March 2024 Issue Front Cover

Latest Issue  

• Volume 20 • Issue 2 • March 2024

March 2024

March 2024 Issue